Compare IFBD & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IFBD | BFRI |
|---|---|---|
| Founded | 2001 | 1997 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 8.4M |
| IPO Year | 2021 | 2021 |
| Metric | IFBD | BFRI |
|---|---|---|
| Price | $0.99 | $0.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 19.1K | ★ 86.5K |
| Earning Date | 05-01-2023 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,861,442.00 | ★ $37,164,000.00 |
| Revenue This Year | N/A | $9.70 |
| Revenue Next Year | N/A | $10.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1520.48 | 5.11 |
| 52 Week Low | $0.88 | $0.54 |
| 52 Week High | $2.70 | $1.87 |
| Indicator | IFBD | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 24.31 |
| Support Level | $0.93 | $0.70 |
| Resistance Level | $1.15 | $0.75 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 20.25 | 5.51 |
Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.